CompanyGraph
Tongling Jieya Biologic Technology Co. Ltd.
301108 · SZSE · China
babywipes.com.cnFinancials as of FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- FinancialsAltman Z-Score 6.85: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.40%
Annual Rate
CNY 0.15Paid annual
Payout Ratio
26.8%Sustainable
Last Ex-Dividend
May 20, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
3.99BCNY591.94M · vs all stocks (USD)
Trailing P/E
59.02xvs Household & Personal Products peers
Revenue (TTM)
840.58MCNY124.84M · vs all stocks (USD)
Profit Margin
9.22%vs Household & Personal Products peers
Beta
0.2380xvs all stocks
52-Week Change
25.25%vs all stocks
Market Capitalization
3.99BCNY591.94M · vs all stocks (USD)
Enterprise Value
3.38BCNY502.27M · vs all stocks (USD)
Trailing P/E
59.02xvs Household & Personal Products peers
Forward P/E
22.75xvs Household & Personal Products peers
Price to Sales (TTM)
5.06xvs Household & Personal Products peers
Price to Book (MRQ)
2.24xvs Household & Personal Products peers
Enterprise to Revenue
4.02xvs Household & Personal Products peers
Enterprise to EBITDA
24.98xvs Household & Personal Products peers
Gross Margin
24.99%vs Household & Personal Products peers
Profit Margin
9.22%vs Household & Personal Products peers
Operating Margin
8.90%vs Household & Personal Products peers
Return on Assets (TTM)
2.64%vs Household & Personal Products peers
Return on Equity (TTM)
4.16%vs Household & Personal Products peers
Revenue (TTM)
840.58MCNY124.84M · vs all stocks (USD)
Revenue per Share (TTM)
6.84CNYUpdated Aug 20, 2026Quarterly Revenue Growth
55.50%vs Household & Personal Products peers
Gross Profit (TTM)
210.75MCNY31.30M · vs all stocks (USD)
EBITDA (TTM)
82.74MCNY12.29M · vs all stocks (USD)
Net Income (TTM)
77.48MCNY11.51M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
2.00%vs Household & Personal Products peers
Operating Cash Flow (TTM)
124.25MCNY18.45M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-434.84MCNY-64.58M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1500CNYUpdated Aug 20, 2026Trailing Annual Dividend Yield
0.40%vs all stocks
Payout Ratio
26.78%vs Household & Personal Products peers
Revenue
772.01MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
575.65MCNYFY2025 · Dec 31, 2025Gross Profit
196.36MCNYFY2025 · Dec 31, 2025Operating Income
101.36MCNY15.05M · vs all stocks (USD)
Pre-tax Income
86.58MCNYFY2025 · Dec 31, 2025Income Tax Expense
9.18MCNYFY2025 · Dec 31, 2025Net Income
77.40MCNYFY2025 · Dec 31, 2025EBIT
87.98MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
164.20MCNYFY2025 · Dec 31, 2025Research & Development
28.19MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
21.26MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.63MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
7.87MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.39MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.6800CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.6800CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
113.63MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
113.63MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
77.40MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-132.42KCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-130.47MCNYFY2025 · Dec 31, 2025Free Cash Flow
-495.67MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
558.64MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
77.40MCNYFY2025 · Dec 31, 2025Other Non-cash Items
3.73MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-182.88MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-28.71MCNYFY2025 · Dec 31, 2025Capital Expenditures
-365.20MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.73BCNYFY2025 · Dec 31, 2025Sale of Investments
2.26BCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
160.44MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-19.30MCNYFY2025 · Dec 31, 2025Other Financing Charges
-74.11MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-93.40MCNYFY2025 · Dec 31, 2025Shares Outstanding
112.56MSharesUpdated Aug 20, 2026Float Shares
35.30MSharesUpdated Aug 20, 2026% Held by Insiders
57.75%vs all stocks
% Held by Institutions
18.85%vs all stocks
Total Cash (MRQ)
967.73MCNY143.73M · vs all stocks (USD)
Total Cash per Share (MRQ)
8.60CNYUpdated Aug 20, 2026Total Debt (MRQ)
98.29MCNY14.60M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0518xvs Household & Personal Products peers
Current Ratio (MRQ)
3.66xvs Household & Personal Products peers
Book Value per Share (MRQ)
16.85CNYUpdated Aug 20, 2026Total Assets
2.33BCNY345.80M · vs all stocks (USD)
Total Current Assets
1.55BCNYFY2025 · Dec 31, 2025Total Liabilities
446.44MCNYFY2025 · Dec 31, 2025Total Non-current Assets
780.39MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
62.92MCNYFY2025 · Dec 31, 2025Total Current Liabilities
383.53MCNYFY2025 · Dec 31, 2025Cash
558.64MCNYFY2025 · Dec 31, 2025Cash Equivalents
90.58MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
649.22MCNYFY2025 · Dec 31, 2025Other Short-term Investments
248.81MCNYFY2025 · Dec 31, 2025Accounts Receivable
236.44MCNYFY2025 · Dec 31, 2025Inventory
90.64MCNYFY2025 · Dec 31, 2025Accounts Payable
281.36MCNYFY2025 · Dec 31, 2025Short-term Debt
4.35MCNYFY2025 · Dec 31, 2025Other Current Liabilities
131.65KCNYFY2025 · Dec 31, 2025Long-term Debt
27.65MCNYFY2025 · Dec 31, 2025Common Stock (Book)
112.56MCNYFY2025 · Dec 31, 2025Retained Earnings
735.12MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
1.88BCNY279.50M · vs all stocks (USD)
52-Week Low
21.23CNYUpdated Aug 20, 202652-Week High
39.43CNYUpdated Aug 20, 202652-Week Change
25.25%vs all stocks
Beta
0.2380xvs all stocks
50-Day MA
29.37CNYUpdated Aug 20, 2026200-Day MA
30.33CNYUpdated Aug 20, 2026Avg 10-Day Volume
1.85MSharesUpdated Aug 20, 2026Avg 30-Day Volume
3.02MSharesUpdated Aug 20, 2026Diluted EPS (TTM)
0.6400CNYUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 6.85: safe zoneNotable
Altman Z-Score: 6.85
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Senco Gold Ltd.
Tier 1ProductionBrand-Compounding ConsumerAttentionFlow
Modern Mills Co.
Tier 1ProductionBrand-Compounding ConsumerFlowRule
PZ Cussons plc
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Shandong Oriental Ocean Group Co., Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowRule
Ganyuan Foods Co., Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Youyou Foods Co., Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowRule
Industri Jamu dan Farmasi Sido Muncul Tbk.
Tier 1ProductionBrand-Compounding ConsumerRule
Maxell Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowRule
Bestore Co. Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Zhejiang Zoenn Design Co., Ltd.
Tier 1ProductionBrand-Compounding ConsumerFlowAttention
Companies that share active interpretations — structural patterns currently present in both stocks.
PC Connection, Inc.
1 interpretationLow-Leverage Liquidity Configuration
Castle Biosciences, Inc.
1 interpretationLow-Leverage Liquidity Configuration
Dyne Therapeutics Inc.
1 interpretationLow-Leverage Liquidity Configuration